MedTrace Logo

Real Life Lipid Management in Hospitals Not Participating in PENELOPE Trial - Control Population for PENELOPE

NCT05659888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 827

Last updated 2024-07-26

No results posted yet for this study

Summary

Guideline recommended evidence-based clinical care correlates with improved patient outcomes. In real life care, however, adherence to guideline recommendations remains suboptimal. In real life, patients may receive suboptimal treatment and as a result treatment targets are not always met. To support and improve secondary prevention for cardiovascular disease, PENELOPE and PENELOPE-CTRL are designed to support guideline implementation on lipid management and provide valuable feedback to care-givers on real world data.

Conditions

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Clinical Operations WCN B.V.

    lead NETWORK

Principal Investigators

  • Marco Alings · WCN

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-25
Primary Completion
2023-01-31
Completion
2023-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05659888 on ClinicalTrials.gov